Treating chemotherapy-induced neutropenia. The most common complication of chemotherapeutic treatment of cancer is the development of neutropenia owing to bone marrow damage. Low neutrophil levels ...

These supportive-care drugs are used to reduce the risk of a life-threatening complication called febrile neutropenia in cancer patients undergoing chemotherapy. HICOR is an institute at Fred Hutch ...

Incredible” results from the PATINA trial suggested a new standard of care for HER2, ER-positive metastatic breast cancer.

Monjuvi plus Revlimid and Rituxan demonstrated improved progression-free survival for patients with relapsed or refractory follicular lymphoma.

Medically reviewed by Marla Anderson, MD "Chemo fever" is a term used to describe a fever caused by chemotherapy treatment, ...

An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate (MTX), according to a new study by investigators ...

The Food and Drug Administration (FDA) has approved Tevimbra (tislelizumab-jsgr) in combination with platinum and fluoropyrimidine-based chemotherapy as a first-line treatment for adults with ...

Tislelizumab-jsgr (Tevimbra) was approved in combination with chemotherapy for the treatment of unresectable or metastatic ...